Bio-Techne Corp (TECH) financial statements (2021 and earlier)
Company profile
| Business Address |
614 MCKINLEY PL N E MINNEAPOLIS, MN 55413 |
| State of Incorp. | MN |
| Fiscal Year End | June 30 |
| SIC | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 110 | 101 | 122 | 158 | 96 | ||
| Cash and cash equivalents | 110 | 101 | 122 | 92 | 64 | ||
| Short-term investments | 66 | 32 | |||||
| Receivables | 112 | 137 | 120 | 117 | 93 | ||
| Inventory, net of allowances, customer advances and progress billings | 95 | 91 | 86 | 60 | 57 | ||
| Inventory | 95 | 91 | 86 | 60 | 57 | ||
| Other current assets | 14 | 18 | 11 | 13 | 8 | ||
| Other undisclosed current assets | 134 | 65 | 60 | ||||
| Total current assets: | 465 | 413 | 398 | 348 | 254 | ||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 76 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 164 | 154 | 145 | 135 | 132 | ||
| Intangible assets, net (including goodwill) | 1,284 | 1,312 | 1,044 | 1,031 | 741 | ||
| Goodwill | 734 | 733 | 598 | 579 | 431 | ||
| Intangible assets, net (excluding goodwill) | 550 | 579 | 446 | 452 | 311 | ||
| Other noncurrent assets | 9 | 6 | 5 | 44 | 2 | ||
| Total noncurrent assets: | 1,533 | 1,472 | 1,195 | 1,210 | 876 | ||
| TOTAL ASSETS: | 1,998 | 1,884 | 1,593 | 1,558 | 1,130 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 61 | 77 | 72 | 64 | 46 | ||
| Accounts payable | 19 | 16 | 18 | 17 | 21 | ||
| Accrued liabilities | 11 | 26 | 21 | 19 | 8 | ||
| Employee-related liabilities | 19 | 29 | 24 | 27 | 15 | ||
| Taxes payable | 13 | 6 | 9 | 2 | 2 | ||
| Deferred revenue | 12 | 9 | ✕ | ✕ | ✕ | ||
| Debt | 22 | 13 | |||||
| Due to related parties | 4 | ||||||
| Business combination, contingent consideration, liability | 10 | 3 | 65 | ||||
| Deferred revenue and credits | ✕ | ✕ | 6 | 5 | |||
| Other undisclosed current liabilities | 7 | ||||||
| Total current liabilities: | 105 | 102 | 80 | 136 | 54 | ||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation, including: | 370 | 493 | 339 | 344 | 92 | ||
| Operating lease, liability | 72 | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed long-term debt and lease obligation | 299 | 493 | 339 | 344 | 92 | ||
| Liabilities, other than long-term debt | 23 | 34 | 96 | 129 | 105 | ||
| Deferred tax liabilities, net | ✕ | 86 | 121 | 63 | |||
| Other liabilities | 21 | 25 | 9 | 5 | 3 | ||
| Business combination, contingent consideration, liability | 3 | 9 | 3 | 39 | |||
| Total noncurrent liabilities: | 394 | 527 | 435 | 473 | 196 | ||
| Total liabilities: | 499 | 629 | 514 | 609 | 250 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent | 1,323 | 1,166 | 1,079 | 950 | 879 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 363 | 317 | 247 | 199 | 179 | ||
| Accumulated other comprehensive loss | (78) | (84) | (45) | (49) | (70) | ||
| Retained earnings | 1,039 | 932 | 877 | 799 | 771 | ||
| Total stockholders' equity: | 1,323 | 1,166 | 1,079 | 950 | 879 | ||
| Other undisclosed liabilities and equity | 176 | 90 | |||||
| TOTAL LIABILITIES AND EQUITY: | 1,998 | 1,884 | 1,593 | 1,558 | 1,130 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | ||
|---|---|---|---|---|---|---|
| Revenues | 752 | 714 | 643 | 563 | 499 | |
| Revenue, net | ✕ | ✕ | 563 | 499 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (255) | (241) | (211) | (188) | (162) | |
| Gross profit: | 496 | 473 | 432 | 375 | 337 | |
| Operating expenses | (339) | (327) | (296) | (254) | (186) | |
| Operating income: | 157 | 147 | 136 | 121 | 151 | |
| Nonoperating income (expense) | 57 | (35) | (10) | (9) | (3) | |
| Other nonoperating income (expense) | 77 | (14) | (0) | (2) | (2) | |
| Interest and debt expense | (21) | (22) | (10) | (7) | (2) | |
| Income from continuing operations before equity method investments, income taxes: | 192 | 90 | 116 | 105 | 146 | |
| Other undisclosed income from continuing operations before income taxes | 21 | 22 | 10 | 7 | 2 | |
| Income from continuing operations before income taxes: | 214 | 112 | 126 | 112 | 147 | |
| Income tax expense (benefit) | (47) | (16) | 0 | (36) | (43) | |
| Net income: | 167 | 96 | 126 | 76 | 104 | |
| Other undisclosed net loss attributable to parent | (0) | (0) | ||||
| Net income attributable to parent: | 167 | 96 | 126 | 76 | 104 | |
| Undistributed earnings (loss) allocated to participating securities, basic | (0) | (0) | (0) | ✕ | ✕ | |
| Net income available to common stockholders, diluted: | 167 | 96 | 126 | 76 | 104 | |
Comprehensive Income ($ in millions)
| 12/31/2019 TTM | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | ||
|---|---|---|---|---|---|---|
| Net income: | 167 | 96 | 126 | 76 | 104 | |
| Other comprehensive income (loss) | 21 | (40) | ||||
| Comprehensive income: | 167 | 96 | 126 | 98 | 65 | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (3) | (14) | 4 | |||
| Comprehensive income, net of tax, attributable to parent: | 164 | 82 | 130 | 98 | 65 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.